メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

日本のドラッグデリバリー装置市場の将来展望:中央静脈カテーテル、輸液システム、ニードルフリー注射器、定量噴霧吸入器 (MDI)

Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

発行 GlobalData 商品コード 537213
出版日 ページ情報 英文 122 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.96円で換算しております。
Back to Top
日本のドラッグデリバリー装置市場の将来展望:中央静脈カテーテル、輸液システム、ニードルフリー注射器、定量噴霧吸入器 (MDI) Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
出版日: 2017年08月01日 ページ情報: 英文 122 Pages
概要

当レポートでは、日本における各種のドラッグデリバリー装置 (薬剤送達装置) の市場について分析し、全体的な市場動向の推移や見通し (過去・今後8年間分)、製品カテゴリー別の詳細動向、主要企業・流通チャネルの市場シェア、主なパイプライン製品の現在の治験状況、昨今の資本取引・事業展開の動き、主要企業のプロファイルなどについて調査しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの概要
  • ドラッグデリバリー装置市場の内訳
  • 当レポートの分析対象市場の定義

第3章 日本のドラッグデリバリー装置市場

  • 市場収益額動向:金額ベース (通算15年間分)
  • 市場収益額の構造:金額ベース
  • 市場収益額:カテゴリー別シェア
  • 市場収益額:カテゴリー別シェアの比較 (通算15年間分)
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模動向:数量ベース (通算15年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:企業別

第4章 日本の中央静脈カテーテル市場

  • 市場収益額の構造:金額ベース
  • 市場収益額:カテゴリー別シェア
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第5章 日本の輸液システム市場

  • 市場収益額の構造:金額ベース
  • 市場収益額:カテゴリー別シェア
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
    • 携帯型輸液ポンプの市場収益額:実績値・予測値 (通算15年間分)
    • シリンジポンプの市場収益額:実績値・予測値 (通算15年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
    • 携帯型輸液ポンプの市場規模:実績値・予測値 (通算15年間分)
    • シリンジポンプの市場規模:実績値・予測値 (通算15年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第6章 日本のニードルフリー注射器市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第7章 日本の定量噴霧吸入器 (MDI) 市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第8章 主要企業のプロファイル:日本のドラッグデリバリー装置市場

  • テルモ
    • 企業概要
  • GlaxoSmithKline Plc
  • Teleflex Inc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Merck & Co Inc
  • B. Braun Melsungen AG
  • ニプロ
  • Baxter International Inc
  • Smiths Medical
  • Becton Dickinson and Co
  • Hospira Inc
  • Fresenius Kabi AG
  • Medtronic plc

第9章 ドラッグデリバリー装置市場のパイプライン製品

第10章 資本取引環境

  • 資産取引
  • 株式発行
  • 事業提携

第11章 近年の主な動き

  • 企業からの発表 (コーポレート・コミュニケーション)
  • 決算発表
  • 政府・公益関係
  • 法令・規制関連
  • その他の主な動き
  • 製品ニュース
  • 戦略・事業計画

第12章 付録

目次
Product Code: GDMEMC0251DB

GlobalData's new report, "Japan Drug Delivery Devices Market Outlook to 2023", provides key market data on the Japan Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope:

  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Japan Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy:

  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Drug Delivery Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Drug Delivery Devices Market, Japan

  • 3.1. Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2023
  • 3.2. Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016
  • 3.3. Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016
  • 3.4. Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023
  • 3.5. Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2016
  • 3.6. Drug Delivery Devices Market, Japan, Revenue ($m), 2016-2023
  • 3.7. Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023
  • 3.8. Drug Delivery Devices Market, Japan, Volume (Units), 2009-2016
  • 3.9. Drug Delivery Devices Market, Japan, Volume (Units), 2016-2023
  • 3.10. Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), 2016

4. Central Venous Catheters Market, Japan

  • 4.1. Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016
  • 4.2. Central Venous Catheters Market, Japan, Segment Contribution (%), 2016
  • 4.3. Central Venous Catheters Market, India, Revenue ($m), 2009-2016
  • 4.4. Central Venous Catheters Market, India, Revenue ($m), 2016-2023
  • 4.5. Central Venous Catheters Market, India, Volume (Units), 2009-2016
  • 4.6. Central Venous Catheters Market, India, Volume (Units), 2016-2023
  • 4.7. Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016
  • 4.8. Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016

5. Infusion Systems Market, Japan

  • 5.1. Infusion Systems Market, Japan, Revenue Mix ($m), 2016
  • 5.2. Infusion Systems Market, Japan, Segment Contribution (%), 2016
  • 5.3. Infusion Systems Market, Japan, Revenue ($m), 2009-2016
  • 5.4. Infusion Systems Market, Japan, Revenue ($m), 2016-2023
    • 5.4.1. Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016
    • 5.4.2. Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016
    • 5.4.3. Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023
    • 5.4.4. Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023
  • 5.5. Infusion Systems Market, Japan, Volume (Units), 2009-2016
  • 5.6. Infusion Systems Market, Japan, Volume (Units), 2016-2023
    • 5.6.1. Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2009-2016
    • 5.6.2. Syringe Pumps Market, Japan, Volume (Units), by Segment, 2009-2016
    • 5.6.3. Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2016-2023
    • 5.6.4. Syringe Pumps Market, Japan, Volume (Units), by Segment, 2016-2023
  • 5.7. Infusion Systems Market, Japan, Distribution Share by Revenue ($m), 2015-2016
  • 5.8. Infusion Systems Market, Japan, Company Share by Revenue ($m), 2016

6. Needle Free Injections Market, Japan

  • 6.1. Needle Free Injections Market, Japan, Revenue ($m), 2009-2016
  • 6.2. Needle Free Injections Market, Japan, Revenue ($m), 2016-2023
  • 6.3. Needle Free Injections Market, Japan, Volume (Units), 2009-2016
  • 6.4. Needle Free Injections Market, Japan, Volume (Units), 2016-2023
  • 6.5. Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), 2015-2016
  • 6.6. Needle Free Injections Market, Japan, Company Share by Revenue ($m), 2016

7. Metered Dose Inhaler Devices Market, Japan

  • 7.1. Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2009-2016
  • 7.2. Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2016-2023
  • 7.3. Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2009-2016
  • 7.4. Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2016-2023
  • 7.5. Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), 2015-2016
  • 7.6. Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), 2016

8. Overview of Key Companies in Japan, Drug Delivery Devices Market

  • 8.1. Terumo Corp
    • 8.1.1. Company Overview
  • 8.2. GlaxoSmithKline Plc
    • 8.2.1. Company Overview
  • 8.3. Teleflex Inc
    • 8.3.1. Company Overview
  • 8.4. AstraZeneca Plc
    • 8.4.1. Company Overview
  • 8.5. Boehringer Ingelheim GmbH
    • 8.5.1. Company Overview
  • 8.6. Pfizer Inc
    • 8.6.1. Company Overview
  • 8.7. Merck & Co Inc
    • 8.7.1. Company Overview
  • 8.8. B. Braun Melsungen AG
    • 8.8.1. Company Overview
  • 8.9. Nipro Corp
    • 8.9.1. Company Overview
  • 8.10. Baxter International Inc
    • 8.10.1. Company Overview
  • 8.11. Smiths Medical
    • 8.11.1. Company Overview
  • 8.12. Becton Dickinson and Co
    • 8.12.1. Company Overview
  • 8.13. Hospira Inc
    • 8.13.1. Company Overview
  • 8.14. Fresenius Kabi AG
    • 8.14.1. Company Overview
  • 8.15. Medtronic plc
    • 8.15.1. Company Overview

9. Drug Delivery Devices Market Pipeline Products

10. Financial Deals Landscape

  • 10.1. Asset Transactions
    • 10.1.1. ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • 10.2. Equity Offerings
    • 10.2.1. Solasia Pharma to Raise USD31.9 Million in IPO
  • 10.3. Partnerships
    • 10.3.1. Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
    • 10.3.2. Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
    • 10.3.3. Terumo to Enter into Agreement with Phosphagenics
    • 10.3.4. Pfizer Terminates its Licensing Agreement with pSivida
    • 10.3.5. Bayer Enters into Licensing Agreement with DelSiTech
    • 10.3.6. BioCorRx Enters into Licensing Agreement with Therakine

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change
    • 11.1.2. May 08, 2017: Sumitomo Dainippon Pharma announces personnel change
    • 11.1.3. Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers
    • 11.1.4. Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology
    • 11.1.5. Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers
    • 11.1.6. Feb 24, 2017: Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers
    • 11.1.7. Feb 09, 2017: Terumo Announces Change of Executive Officers
    • 11.1.8. Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President
    • 11.1.9. Nov 11, 2016: Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes Related to Officers and Other Key Positions
    • 11.1.10. Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development
  • 11.2. Financial Announcements
    • 11.2.1. Jul 29, 2016: Summary of Consolidated Financial Results For the First Quarter of the Fiscal Year Ending March 31, 2017
  • 11.3. Government and Public Interest
    • 11.3.1. Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell
    • 11.3.2. Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced
  • 11.4. Legal And Regulatory
    • 11.4.1. Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S.
  • 11.5. Other Significant Developments
    • 11.5.1. Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio
    • 11.5.2. Jan 26, 2017: Achievement of sales milestone for COPD products
    • 11.5.3. Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System
    • 11.5.4. Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy
  • 11.6. Product News
    • 11.6.1. Jun 12, 2017: Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America
    • 11.6.2. Jan 30, 2017: Terumo launches user friendly PLAJEX Luer Lock with Threaded Closure (TC)
    • 11.6.3. Jan 26, 2017: Terumo and Nemera announce compatibility between PLAJEX polymer prefillable syringes and Safe'n'Sound
  • 11.7. Strategy And Business Planning
    • 11.7.1. Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017
    • 11.7.2. Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha
    • 11.7.3. Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure
    • 11.7.4. Jan 31, 2017: Terumo Opens a Branch in Yangon

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
    • 12.1.6. Benchmarking
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023
  • Table 2: Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016
  • Table 3: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023
  • Table 4: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 6: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023
  • Table 7: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016
  • Table 8: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023
  • Table 9: Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
  • Table 10: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016
  • Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
  • Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
  • Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016
  • Table 17: Infusion Systems Market, Japan, Segment Contribution (%), 2016
  • Table 18: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 19: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 20: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 21: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 24: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016
  • Table 25: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023
  • Table 26: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016
  • Table 27: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016
  • Table 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
  • Table 29: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
  • Table 30: Infusion Systems Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 31: Infusion Systems Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
  • Table 32: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 34: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016
  • Table 35: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023
  • Table 36: Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 37: Needle Free Injections Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
  • Table 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016
  • Table 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023
  • Table 42: Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 43: Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
  • Table 44: Drug Delivery Devices Market Pipeline Products
  • Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • Table 46: Solasia Pharma to Raise USD31.9 Million in IPO
  • Table 47: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
  • Table 48: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
  • Table 49: Terumo to Enter into Agreement with Phosphagenics
  • Table 50: Pfizer Terminates its Licensing Agreement with pSivida
  • Table 51: Bayer Enters into Licensing Agreement with DelSiTech
  • Table 52: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures

  • Figure 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023
  • Figure 2: Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016
  • Figure 3: Drug Delivery Devices Market, Japan, Category Contribution (%), 2016
  • Figure 4: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023
  • Figure 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 6: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 7: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023
  • Figure 8: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016
  • Figure 9: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023
  • Figure 10: Drug Delivery Devices Market, Japan, Company Share (%) 2016
  • Figure 11: Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016
  • Figure 12: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016
  • Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
  • Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016
  • Figure 18: Infusion Systems Market, Japan, Revenue Mix ($m), 2016
  • Figure 19: Infusion Systems Market, Japan, Segment Contribution (%), 2016
  • Figure 20: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 21: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 24: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 25: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 26: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016
  • Figure 27: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023
  • Figure 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016
  • Figure 29: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016
  • Figure 30: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
  • Figure 31: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
  • Figure 32: Infusion Systems Market, Japan, Company Share (%) 2016
  • Figure 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 34: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 35: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016
  • Figure 36: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023
  • Figure 37: Needle Free Injections Market, Japan, Company Share (%) 2016
  • Figure 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016
  • Figure 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023
  • Figure 42: Metered Dose Inhaler Devices Market, Japan, Company Share (%) 2016
Back to Top